Scalar Market Research

In-Vitro Diagnostics Market Worth USD 77.38 Billion by 2021

The increasing incidences of chronic infectious diseases, the rising geriatric population and the emerging technologies in the field of in-vitro diagnostics are some of the major driving factors for the in-vitro diagnostics (IVD) market.


Chicago, IL -- (SBWIRE) -- 02/21/2017 -- According to the new market research report, "In-Vitro Diagnostics (IVD) Market, by Products (Instruments & Systems and Reagents & Consumables Segments), Applications (Immunochemistry, Clinical Chemistry, Hematology, Infectious Disease, Microbiology, Genetic Testing, and Histology & Cytology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2021", published by Scalar Market Research, the in-vitro diagnostics market is expected to grow at a steady CAGR of 5.2% and become worth USD 77.38 billion by 2021. In 2016, the in-vitro diagnostics market is estimated to be worth USD 60.07 billion.

Download Sample:

The global in-vitro diagnostics market report offers in-depth analysis about the market size (revenue), market share, major market segments, global geographies, forecast, key players, and premium trends. It also focuses on the key drivers and opportunities in this market.

Early buyers can also avail 20% discount and 100% customization on this report, for the month of October.

Enquiry Before Buying:

Few key findings of the report:

The Strong rise in the incidences of chronic diseases and infectious diseases along with the rise in the number of the geriatric population are suggested to drive the business in the in-vitro diagnostics market.

Widespread rise in the instances of infectious diseases and rising demand from the number of chronic disease patients, the report suggests a steady rise in demand for the in-vitro diagnostics market on the global scale.

The impressive rise in the research and development efforts from the key market players is also a significant driving factor for the growth of the in-vitro diagnostics market during the forecast period.

The in-vitro diagnostics market report suggests a steady rise in demand, the growth of the emerging segments such as companion diagnostics, point-of-care tests, lab on a chip and other next generation technologies. These factors are expected to create significant business opportunities for the key players and the emerging players in the in-vitro diagnostics market. The growing demand for evidence-based medicine is also considered to be a key driving factor for this industry. The report highlights immunochemistry as the strongest growing application segment for this industry during the forecast period. Molecular diagnostics in genetic testing and cancer screening are expected to witness ample growth opportunities.

North America is suggested to hold the largest share of the in-vitro diagnostics market. Asia-Pacific, on the other hand, is expected to become the fastest-growing segment of the market during the forecast period. Strong government initiatives, rising awareness about healthcare and improved infrastructure are suggested to be some of the major reasons for the impressive growth of the in-vitro diagnostics market in the Asia-Pacific region.

Browse the Report:

The key players highlighted in the in-vitro diagnostics market report include:

Abbott Laboratories
Becton Dickinson and Company
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
Siemens Healthcare
Thermo Fisher Scientific, Inc.

Browse Related Report:
Prescription Pharmaceuticals Market - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020

About Scalar Market Research
Scalar Market Research, Inc., a U.S.-based market research and consulting firm, aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.

Find out more about our services at:

Moses Nakka
8770 W Bryn Mawr Ave.,
Suite 1300
Chicago, IL 60631
Tel.: 800-213-5170 (U.S./Canada Toll-free)

Follow us on LinkedIn: